Search

Author/Creator Bauer, Todd M

1. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors. Issue 1 (15th March 2020)

Authors:
Naing, Aung; Gainor, Justin F; Gelderblom, Hans; Forde, Patrick M; Butler, Marcus O; Lin, Chia-Chi; Sharma, Sunil; Ochoa de Olza, Maria; Varga, Andrea; Taylor, Matthew; Schellens, Jan H M; Wu, Hongqian; Sun, Haiying; Silva, Antonio P; Faris, Jason; Mataraza, Jennifer; Cameron, Scott; Bauer, Todd M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study. (4th November 2015)

Authors:
Naing, Aung; Infante, Jeffrey R; Papadopoulos, Kyriakos P; Autio, Karen A; Wong, Deborah J; Falchook, Gerald S; Patel, Manish R; Pant, Shubham; Whiteside, Melinda; Bendell, Johanna; Bauer, Todd M; Janku, Filip; Javle, Milind; Colen, Rivka; Tannir, Nizar; Oft, Martin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study. Issue 4 (April 2023)

Authors:
Solomon, Benjamin J; Bauer, Todd M; Mok, Tony S K; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; López, Froylán López; Soo, Ross A; Shaw, Alice T; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriq...
Journal:
Lancet
Issue:
Volume 11:Issue 4(2023)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)

Authors:
Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Ra...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial. Issue 12 (December 2019)

Authors:
Shaw, Alice T; Solomon, Benjamin J; Chiari, Rita; Riely, Gregory J; Besse, Benjamin; Soo, Ross A; Kao, Steven; Lin, Chia-Chi; Bauer, Todd M; Clancy, Jill S; Thurm, Holger; Martini, Jean-Francois; Peltz, Gerson; Abbattista, Antonello; Li, Sherry; Ou, Sai-Hong Ignatius
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1691
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Issue 12 (December 2017)

Authors:
Shaw, Alice T; Felip, Enriqueta; Bauer, Todd M; Besse, Benjamin; Navarro, Alejandro; Postel-Vinay, Sophie; Gainor, Justin F; Johnson, Melissa; Dietrich, Jorg; James, Leonard P; Clancy, Jill S; Chen, Joseph; Martini, Jean-François; Abbattista, Antonello; Solomon, Benjamin J
Journal:
Lancet oncology
Issue:
Volume 18:Issue 12(2017:Dec.)
Page Start:
1590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. Issue 12 (December 2018)

Authors:
Solomon, Benjamin J; Besse, Benjamin; Bauer, Todd M; Felip, Enriqueta; Soo, Ross A; Camidge, D Ross; Chiari, Rita; Bearz, Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M; Riely, Gregory J; Tan, Eng Huat; Seto, Takashi; James, Leonard P; Clancy, Jill S; Abbattista, Antonello; Martini, Jean-François;...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 12(2018)
Page Start:
1654
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Issue 11 (November 2019)

Authors:
Naing, Aung; Wong, Deborah J; Infante, Jeffrey R; Korn, W Michael; Aljumaily, Raid; Papadopoulos, Kyriakos P; Autio, Karen A; Pant, Shubham; Bauer, Todd M; Drakaki, Alexandra; Daver, Naval G; Hung, Annie; Ratti, Navneet; McCauley, Scott; Van Vlasselaer, Peter; Verma, Rakesh; Ferry, David; Oft, Ma...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 11(2019)
Page Start:
1544
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers. (4th November 2015)

Authors:
Gangadhar, Tara C; Hamid, Omid; Smith, David C; Bauer, Todd M; Wasser, Jeffrey S; Luke, Jason J; Balmanoukian, Ani S; Kaufman, David R; Zhao, Yufan; Maleski, Janet; Leopold, Lance; Gajewski, Thomas F
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. Issue 1 (January 2017)

Authors:
Rudin, Charles M; Pietanza, M Catherine; Bauer, Todd M; Ready, Neal; Morgensztern, Daniel; Glisson, Bonnie S; Byers, Lauren A; Johnson, Melissa L; Burris, Howard A; Robert, Francisco; Han, Tae H; Bheddah, Sheila; Theiss, Noah; Watson, Sky; Mathur, Deepan; Vennapusa, Bharathi; Zayed, Hany; Lally, ...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗